Thyroid hormone levels in patients with bipolar disorder: A systematic review and meta- analysis

Author:

Liu Shanshan1,Chen Xiaoai2,Li Xiaotao3,Tian Limin4

Affiliation:

1. Gansu University of Chinese Medicine

2. Jiangsu University

3. Lanzhou University

4. Gansu Provincial Hospital

Abstract

Abstract Purpose To investigate the difference of serum thyroid hormone (TH) levels in bipolar disorder (BD) during different mood episodes (depression and mania) compared with healthy control (HC) and among different mood episodes. Methods We systematically searched the electronic databases for studies on the relationship between BD and TH levels. The random effects model and the standardized mean difference were used to combine the effect sizes. Results Serum T3 (standard mean difference [SMD]: -0.52, 95% confidence interval [CI]: -0.86 to -0.18, P = 0.00), FT3 (SMD: -0.55, 95%CI: -1.06 to -0.04, P = 0.04) decreased significantly in BD-depression compared with HC. Serum TSH(SMD: 0.20, 95%CI: 0.04 to 0.36, P = 0.02), FT4 (SMD: 0.42, 95%CI: 0.17 to 0.66, P = 0.00) increased significantly and T3 (SMD: −0.73, 95%CI: −1.37 to -0.08, P = 0.03) decreased significantly in BD-mania compared with HC; FT4 (SMD: 0.85, 95%CI: 0.56 to 1.13, P = 0.00) increased significantly in males; TSH (SMD: 0.49, 95%CI: 0.21 to 0.78, P = 0.00) increased significantly, T3 (SMD: -0.57, 95%CI: -0.86 to -0.29, P = 0.00) and T4 (SMD: -0.68, 95%CI: -1.34 to -0.01, P = 0.05) decreased significantly in females. Serum T3 (SMD: 0.29, 95%CI: 0.12 to 0.46, P = 0.00), FT3(SMD: 0.55, 95%CI: 0.28 to 0.81, P = 0.00) increased significantly in BD-mania than in BD-depression. Conclusion Serum T3 and FT3 levels decreased significantly in BD-depression compared with HC. Serum TSH, FT4 levels increased significantly and T3 level decreased significantly in BD-mania compared with HC. Serum T3, FT3 levels increased significantly in BD-mania than in BD-depression. The fascinating thing was that gender differences may affect the compensatory secretion of BD-mania anterior pituitary hormone. Trial registration number and date of registration for prospectively registered trials No. CRD42022378530 (4 December 2022)

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3